Andrew Fein

Stock Analyst at HC Wainwright & Co.

(4.03)
# 539
Out of 4,457 analysts
389
Total ratings
46.41%
Success rate
12.3%
Average return

52 Stocks

Annexon
Jun 4, 2024
Reiterates: Buy
Price Target: $30
Current: $5.62
Upside: +433.81%
TScan Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $15
Current: $8.40
Upside: +78.57%
Kymera Therapeutics
Jun 3, 2024
Reiterates: Buy
Price Target: $46
Current: $33.29
Upside: +38.18%
Catalyst Pharmaceuticals
Jun 3, 2024
Reiterates: Buy
Price Target: $26
Current: $15.06
Upside: +72.64%
Merus
May 29, 2024
Maintains: Buy
Price Target: $65$85
Current: $56.55
Upside: +50.31%
Insmed
May 29, 2024
Maintains: Buy
Price Target: $52$70
Current: $63.92
Upside: +9.51%
Biogen
May 23, 2024
Reiterates: Buy
Price Target: $300
Current: $231.69
Upside: +29.48%
Dyne Therapeutics
May 20, 2024
Maintains: Buy
Price Target: $46$48
Current: $33.07
Upside: +45.15%
Arvinas
May 17, 2024
Reiterates: Buy
Price Target: $87
Current: $25.67
Upside: +238.92%
PepGen
May 15, 2024
Reiterates: Buy
Price Target: $26
Current: $17.25
Upside: +50.72%
Unity Biotechnology
May 15, 2024
Reiterates: Buy
Price Target: $8
Current: $1.43
Upside: +459.44%
Liquidia
May 15, 2024
Reiterates: Buy
Price Target: $32
Current: $12.94
Upside: +147.30%
Acumen Pharmaceuticals
May 15, 2024
Reiterates: Buy
Price Target: $15
Current: $2.64
Upside: +468.18%
Syros Pharmaceuticals
May 15, 2024
Reiterates: Buy
Price Target: $15
Current: $6.00
Upside: +150.00%
Sutro Biopharma
May 14, 2024
Reiterates: Buy
Price Target: $12
Current: $3.46
Upside: +246.82%
Fulcrum Therapeutics
May 14, 2024
Reiterates: Buy
Price Target: $17
Current: $7.45
Upside: +128.19%
Savara
May 13, 2024
Reiterates: Buy
Price Target: $6
Current: $4.08
Upside: +47.06%
Amylyx Pharmaceuticals
May 10, 2024
Reiterates: Buy
Price Target: $8
Current: $1.64
Upside: +387.80%
ProQR Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $5
Current: $1.76
Upside: +184.09%
ACADIA Pharmaceuticals
May 9, 2024
Maintains: Buy
Price Target: $33$27
Current: $14.91
Upside: +81.09%
Alector
May 9, 2024
Maintains: Buy
Price Target: $41$35
Current: $4.68
Upside: +647.86%
Prothena Corporation
May 9, 2024
Maintains: Buy
Price Target: $90$84
Current: $20.41
Upside: +311.56%
Keros Therapeutics
May 9, 2024
Reiterates: Buy
Price Target: $100
Current: $49.36
Upside: +102.59%
Kamada
May 9, 2024
Reiterates: Buy
Price Target: $11
Current: $5.09
Upside: +116.11%
Zentalis Pharmaceuticals
May 8, 2024
Maintains: Buy
Price Target: $46$40
Current: $8.84
Upside: +352.49%
DBV Technologies
May 8, 2024
Maintains: Buy
Price Target: $20$10
Current: $1.00
Upside: +902.51%
Denali Therapeutics
May 8, 2024
Reiterates: Buy
Price Target: $95
Current: $20.73
Upside: +358.27%
Vigil Neuroscience
May 8, 2024
Reiterates: Buy
Price Target: $24
Current: $4.33
Upside: +454.27%
Stoke Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $35
Current: $16.25
Upside: +115.38%
Vertex Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $462
Current: $480.73
Upside: -3.90%
Foghorn Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $20
Current: $5.25
Upside: +280.95%
BioCryst Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $30
Current: $6.17
Upside: +386.22%
Protara Therapeutics
May 6, 2024
Reiterates: Buy
Price Target: $23
Current: $2.57
Upside: +794.94%
Blueprint Medicines
May 3, 2024
Maintains: Buy
Price Target: $125$135
Current: $105.55
Upside: +27.90%
KalVista Pharmaceuticals
May 3, 2024
Maintains: Buy
Price Target: $24$20
Current: $12.07
Upside: +65.70%
Neurocrine Biosciences
May 2, 2024
Maintains: Buy
Price Target: $150$160
Current: $135.45
Upside: +18.12%
United Therapeutics
May 2, 2024
Reiterates: Buy
Price Target: $300
Current: $288.06
Upside: +4.14%
I-Mab
Mar 18, 2024
Reiterates: Buy
Price Target: $18$8
Current: $1.84
Upside: +334.78%
AC Immune
Mar 15, 2024
Reiterates: Buy
Price Target: $16
Current: $4.26
Upside: +275.59%
Wave Life Sciences
Mar 7, 2024
Maintains: Buy
Price Target: $8$15
Current: $6.23
Upside: +140.77%
C4 Therapeutics
Nov 2, 2023
Maintains: Buy
Price Target: $17$7
Current: $4.38
Upside: +59.82%
Pulmatrix
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.92
Upside: +421.46%
Bellerophon Therapeutics
Jun 6, 2023
Maintains: Buy
Price Target: $30$2
Current: $0.06
Upside: +3,049.61%
Corbus Pharmaceuticals Holdings
Mar 8, 2023
Reiterates: Buy
Price Target: $3
Current: $50.10
Upside: -94.01%
MEI Pharma
Feb 13, 2023
Maintains: Buy
Price Target: $100$40
Current: $2.90
Upside: +1,279.26%
Matinas BioPharma Holdings
Jan 31, 2023
Reiterates: Buy
Price Target: $3
Current: $0.16
Upside: +1,776.17%
Eloxx Pharmaceuticals
May 9, 2022
Maintains: Neutral
Price Target: $40$20
Current: $0.80
Upside: +2,400.00%
Amarin Corporation
May 5, 2022
Downgrades: Neutral
Price Target: $10$3
Current: $0.78
Upside: +285.55%
Aldeyra Therapeutics
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $3.73
Upside: +302.14%
Aprea Therapeutics
Mar 16, 2022
Maintains: Neutral
Price Target: $80$40
Current: $4.41
Upside: +807.94%
Ocuphire Pharma
Nov 24, 2021
Initiates: Buy
Price Target: n/a
Current: $1.65
Upside: -
Telesis Bio
Mar 18, 2021
Maintains: Buy
Price Target: $576$504
Current: $4.99
Upside: +10,000.20%